Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
SOLD OCT 29, 2025$890,000A3 beds2.5 baths1,810 sq ft36 Calle Maria, Rancho Santa Margarita, CA 92688Innovate Realty, Inc
Asia-Pacific is expected to be the fastest growing region in the GLP-1 receptor agonists obesity drugs market during the forecast period due to increasing obesity rates, rising healthcare awareness, and expanding access to advanced diabetes and obesity care Long-acting GLP-1 Receptor Agonists segment dominated the GLP-1 receptor agonists obesity drugs market with a market share of 55.5% in 2024, driven by its superior weight loss efficacy, once-weekly dosing convenience, and broad adoption of drugs such as semaglutide and tirzepatide Report Scope and GLP-1 Receptor Agonists Obesity Drugs Market Segmentation GLP-1 Receptor Agonists Obesity Drugs Market Trends Expansion Beyond Diabetes Through Multi-Indication Approvals A significant and accelerating trend in the global GLP-1 receptor agonists obesity drugs market is the expansion of these therapies beyond type 2 diabetes into broader indications such as chronic obesity, cardiovascular risk reduction, and potentially even conditions such as sleep apnea and nonalcoholic steatohepatitis (NASH)
The microbiota and autoimmunity: Their role in thyroid autoimmune diseases
Systemic inflammation can hurt fertility
Nutrifactors Glutazon, Gluta Glime, and Gluta Fair are the best glutathione supplements available in Pakistan
US$ 24.52
US$ 22.71
US$ 20.36
US$ 23.55
US$ 26.08
